Telemedicine and Depression Screening After the Start of the COVID-19 Pandemic

Maria E Garcia; John Neuhaus; Jennifer Livaudais-Toman; Mitchell D Feldman; Lisa Ochoa-Frongia; Elaine Khoong; Leah S Karliner

doi:10.1001/jamanetworkopen.2023.55830

Telemedicine and Depression Screening After the Start of the COVID-19 Pandemic

JAMA Netw Open. 2024 Feb 5;7(2):e2355830. doi: 10.1001/jamanetworkopen.2023.55830.

Authors

Maria E Garcia¹, John Neuhaus², Jennifer Livaudais-Toman¹, Mitchell D Feldman¹, Lisa Ochoa-Frongia³, Elaine Khoong³, Leah S Karliner¹

Affiliations

¹ Mt Zion Division of General Internal Medicine, Department of Medicine, University of California, San Francisco.
² Department of Epidemiology and Biostatistics, University of California, San Francisco.
³ Zuckerberg San Francisco General Hospital Division of General Internal Medicine, Department of Medicine, University of California, San Francisco.

No abstract available

Plain language summary

This cohort study investigates the probability of depression screening by visit type and by patient demographic characteristics in a large health system during the early COVID-19 pandemic.

MeSH terms

COVID-19*
Depression / diagnosis
Depression / epidemiology
Humans
Pandemics
Telemedicine*

Grants and funding

K23 HL157750/HL/NHLBI NIH HHS/United States